AGMB (AgomAb Therapeutics NV American Depositary Shares) Stock Analysis - Financials

AgomAb Therapeutics NV American Depositary Shares (AGMB) is a publicly traded the market company. As of May 21, 2026, AGMB trades at $10.69 with a market cap of $520.06M and a P/E ratio of 0.00. AGMB moved +0.76% today. Year to date, AGMB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $9.00 to $17.45. Analyst consensus is strong buy with an average price target of $32.00. Rallies surfaces AGMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are AGMB's key financials?

AGMB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AGMB recently traded at $10.69. Market cap is $520.06M. P/E ratio is 0.00. Revenue is $0.

AGMB Key Metrics

Key financial metrics for AGMB
MetricValue
Price$10.69
Market Cap$520.06M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$17.45
52-Week Low$9.00
Volume12
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest AGMB News

AGMB Analyst Consensus

3 analysts cover AGMB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.00.

Common questions about AGMB

What are AGMB's key financials?
AGMB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AGMB recently traded at $10.69. Market cap is $520.06M. P/E ratio is 0.00. Revenue is $0.
Is AGMB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AGMB. It does not provide personalized investment advice.
AGMB

AGMB